Redefining Phenotyping for Clinical Advancements and Variant Prioritization
FDNA’s CEO, Dekel Gelbman, joined two distinguished members of the genetics community—Dr. John Carey (University of Utah) and Dr. Christine Read more
FDNA Insights
The Genomics Collaborative: How to Design the Future of Health—Together
ThinkGenetic recently hosted a panel discussion among researchers involved in the Genomics Collaborative, an FDNA initiative connecting researchers, clinicians, Read more
AI in Healthcare: Separating the Hype from the Hope
FDNA’s CEO Dekel Gelbman recently spoke to hundreds of leaders during the Stanford Big Data in Precision Health Summit. The Read more
“Where are the limits?”
Big data, next-generation phenotyping, and the possibilities for precision medicine This post is based on a presentation given at the Read more
FDNA and Face2Gene Featured at ESHG
A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s Read more
What to Do and See at ESHG
The European Society of Human Genetics (ESHG) 42nd Annual Meeting 2018 MiCo – Milano Congressi · Milan, Italy · June Read more
Artificial Intelligence in Drug Discovery: A Conversation with Dekel Gelbman, CEO of FDNA
“When you talk about precision medicine every disease can become somewhat of a rare disease because you’re going to Read more
The Road to Precision Medicine: Balancing Ethics and Efficiency
Artificial intelligence has increasingly become the basis for advancing precision medicine. Tomorrow, at the ReWork Deep Learning in Healthcare Summit Read more
Patient Participation Proves Invaluable for Both the Diagnosed and Undiagnosed
For the young and undiagnosed, having a doctor who can recognize their disease can make the difference between entering a Read more
Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> Read more
Dr. John Carey: Delineating Genetic Syndromes and Next-Generation Phenotyping
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more
Dr. Karen Gripp: Face2Gene RESEARCH for Deep Phenotyping of Novel Syndromes
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more
FDNA’s Keynote at ePharma: Using Next-Generation Phenotyping For Precision Medicine Across the Pharma Value Chain
NOTE: This post is based on a presentation made at the March 2018 ePharma conference in New York City. Read more